Sanofi

Sanofi

Verified
A global integrated healthcare leader discovers, develops and distributes therapeutic solutions.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$133.1b (Public information from Jun 2024)
Paris Île-de-France (HQ)
Corporate Venture Fund: Sanofi Ventures

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2020202120222023202420252026
Revenues37.4b39.2b45.4b46.4b46.3b50.0b52.8b
% growth(1 %)5 %16 %2 %-8 %6 %
EBITDA9.8b10.8b13.8b15.2b13.6b15.5b16.6b
% EBITDA margin26 %27 %30 %33 %29 %31 %31 %
Profit12.3b6.2b6.7b5.4b7.1b8.7b9.6b
% profit margin33 %16 %15 %12 %15 %17 %18 %
EV / revenue2.9x3.1x2.6x2.6x2.6x2.4x2.1x
EV / EBITDA11.0x11.3x8.7x7.9x9.0x7.6x6.8x
R&D budget5.5b5.7b6.7b6.7b---
R&D % of revenue15 %15 %15 %14 %---

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO

$310m

Post IPO Equity

$30.8m

Grant

$2.0b

Grant
*

$229k

-
Total Funding$2.0b

Recent News about Sanofi

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
  • Edit
Kymab
ACQUISITION by Sanofi Jan 2021
Principia BioPharma
ACQUISITION by Sanofi Aug 2020
Ablynx
ACQUISITION by Sanofi Jan 2018
Kiadis Pharma
ACQUISITION by Sanofi Apr 2021
Kadmon
ACQUISITION by Sanofi Sep 2021
Translate Bio
ACQUISITION by Sanofi Aug 2021
View 84 more